| Product Code: ETC12012189 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Despite a significant decrease in the compound annual growth rate (CAGR) from 2020 to 2024, Nigeria continues to heavily rely on drug imports for schistosomiasis treatment. The top exporting countries in 2024 include India, China, Netherlands, Metropolitan France, and the USA, indicating a diverse source of pharmaceutical products. However, the high Herfindahl-Hirschman Index (HHI) concentration suggests a lack of market competition. The negative growth rates in both CAGR and year-on-year growth indicate potential challenges in the market, requiring strategic interventions to ensure sustainable access to essential medications for combating schistosomiasis in Nigeria.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Drugs for Schistosomiasis Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Drugs for Schistosomiasis Market - Industry Life Cycle |
3.4 Nigeria Drugs for Schistosomiasis Market - Porter's Five Forces |
3.5 Nigeria Drugs for Schistosomiasis Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Nigeria Drugs for Schistosomiasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 Nigeria Drugs for Schistosomiasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Nigeria Drugs for Schistosomiasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Nigeria Drugs for Schistosomiasis Market Trends |
6 Nigeria Drugs for Schistosomiasis Market, By Types |
6.1 Nigeria Drugs for Schistosomiasis Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, By Praziquantel, 2021 - 2031F |
6.1.4 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, By Oxamniquine, 2021 - 2031F |
6.1.5 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, By Metrifonate, 2021 - 2031F |
6.1.6 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, By Artesunate, 2021 - 2031F |
6.2 Nigeria Drugs for Schistosomiasis Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.2.3 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.2.4 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.2.5 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, By Government Programs, 2021 - 2031F |
6.3 Nigeria Drugs for Schistosomiasis Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.4 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, By Public Health Organizations, 2021 - 2031F |
6.3.5 Nigeria Drugs for Schistosomiasis Market Revenues & Volume, By Clinics, 2021 - 2031F |
7 Nigeria Drugs for Schistosomiasis Market Import-Export Trade Statistics |
7.1 Nigeria Drugs for Schistosomiasis Market Export to Major Countries |
7.2 Nigeria Drugs for Schistosomiasis Market Imports from Major Countries |
8 Nigeria Drugs for Schistosomiasis Market Key Performance Indicators |
9 Nigeria Drugs for Schistosomiasis Market - Opportunity Assessment |
9.1 Nigeria Drugs for Schistosomiasis Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Nigeria Drugs for Schistosomiasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 Nigeria Drugs for Schistosomiasis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Nigeria Drugs for Schistosomiasis Market - Competitive Landscape |
10.1 Nigeria Drugs for Schistosomiasis Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Drugs for Schistosomiasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |